Picard Medical is trading 5.16% up at $6.72 as its September rally continues; the move appears primarily driven by speculative momentum and heavy volatility.
- Shares gained 20.86% on September 11 and 17.45% on September 14.
- No new company-specific announcement was identified for September 16, 2026.
- The broader backdrop was modestly supportive, with the Nasdaq up 0.79% as investors awaited the Federal Reserve decision.